back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-03 15:35 Tx date 2025-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+225,000 vol |
667,000 | |
| Filed 2024-06-18 15:48 Tx date 2024-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+130,000 vol |
442,000 | |
| Filed 2023-06-26 12:44 Tx date 2023-06-23 |
$DMAC
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$39,100
+10,000 vol $3.91 each |
34,330 | |
| Filed 2023-06-05 16:59 Tx date 2023-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+67,000 vol |
312,000 | |
| Filed 2022-02-08 19:08 Tx date 2021-07-28 |
$DMAC
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
1,199,750 | |
| Filed 2022-02-08 19:07 Tx date 2022-02-08 |
$DMAC
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
99 - Correction of information
|
-954,750 vol |
245,000 | |
| Filed 2022-02-08 19:05 Tx date 2021-07-28 |
$DMAC
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
||
| Filed 2022-02-08 19:00 Tx date 2022-02-08 |
$DMAC
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
-75,520 vol |
24,330 | |
| Filed 2022-02-08 18:59 Tx date 2021-08-16 |
$DMAC
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$31,463
+10,000 vol $3.15 each |
99,850 | |
| Filed 2022-02-08 18:54 Tx date 2021-08-16 |
$DMAC
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$31,463
+10,000 vol $3.15 each |
||
| Filed 2022-02-08 18:48 Tx date 2021-08-16 |
$DMAC
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$31,463
+10,000 vol $3.15 each |
||
| Filed 2020-06-02 18:18 Tx date 2020-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
1,139,750 | |
| Filed 2019-08-19 15:14 Tx date 2019-08-19 |
$DMA
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,290
+3,000 vol $2.43 each |
89,850 | |
| Filed 2019-06-27 12:02 Tx date 2019-06-24 |
$DMA
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+99,750 vol |
1,104,750 | |
| Filed 2019-05-30 13:21 Tx date 2019-05-24 |
$DMA
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,770
+4,000 vol $2.94 each |
86,850 | |
| Filed 2018-12-11 Tx date 2018-12-11 |
$DMA
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
+1,250 vol |
82,850 | |
| Filed 2018-07-17 Tx date 2018-04-17 |
$DMA
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$562,800
+1,005,000 vol $0.56 each |
||
| Filed 2018-07-17 Tx date 2018-04-17 |
$DMA
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$562,800
+1,005,000 vol $0.56 each |
||
| Filed 2018-07-12 Tx date 2018-03-29 |
$DMA
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$6,324
+20,400 vol $0.31 each |
40,800 | |
| Filed 2018-07-12 Tx date 2018-04-17 |
$DMA
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$562,800
+1,005,000 vol $0.56 each |
2,010,000 | |
| Filed 2018-07-12 Tx date 2018-03-29 |
$DMA
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,648
+40,800 vol $0.31 each |
81,600 | |
| Filed 2018-04-25 Tx date 2018-04-05 |
$DMA
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-25 Tx date 2018-03-29 |
$DMA
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$7,140
+20,400 vol $0.35 each |
20,400 | |
| Filed 2018-04-25 Tx date 2018-04-17 |
$DMA
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$562,800
+1,005,000 vol $0.56 each |
1,005,000 | |
| Filed 2018-04-25 Tx date 2018-04-05 |
$DMA
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-25 Tx date 2018-04-05 |
$DMA
DiaMedica Therapeutics Inc. |
Kellen, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
40,800 |